Cargando…

Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment

Brain glucose hypometabolism is an early sign of Alzheimer’s disease (AD), and interventions which offset this deficit, such as ketogenic diets, show promise as AD therapeutics. Conversely, high-fat feeding may exacerbate AD risk. We analyzed the metabolomic profile of cerebrospinal fluid (CSF) in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanson, Angela J., Banks, William A., Bettcher, Lisa F., Pepin, Robert, Raftery, Daniel, Navarro, Sandi L., Craft, Suzanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145981/ https://www.ncbi.nlm.nih.gov/pubmed/37110227 http://dx.doi.org/10.3390/metabo13040569

Ejemplares similares

Predictive Modeling of Alzheimer’s and Parkinson’s Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid
por: Hwangbo, Nathan, et al.
Publicado: (2022)

Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment
por: Russin, Kate J., et al.
Publicado: (2021)

Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a randomized trial
por: Kellar, Derek, et al.
Publicado: (2022)

Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
por: Willkommen, Desiree, et al.
Publicado: (2018)

Metabolomics of Cerebrospinal Fluid in Multiple Sclerosis Compared With Healthy Controls: A Pilot Study
por: Židó, Michal, et al.
Publicado: (2022)

Demographic, Health and Lifestyle Factors Associated with the Metabolome in Older Women
por: Navarro, Sandi L., et al.
Publicado: (2023)

Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study
por: Nagpal, Ravinder, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis
por: Gray, Elizabeth, et al.
Publicado: (2015)

Cerebrospinal Fluid Metabolome in Parkinson’s Disease and Multiple System Atrophy
por: Kwon, Do Hyeon, et al.
Publicado: (2022)

Metabolomic Identification in Cerebrospinal Fluid of the Effects of High Dietary Cholesterol in a Rabbit Model of Alzheimer’s Disease
por: Liu, Qing Yan, et al.
Publicado: (2012)

Concordant and Discordant Cerebrospinal Fluid and Plasma Cytokine and Chemokine Responses in Mild Cognitive Impairment and Early-Stage Alzheimer’s Disease
por: de la Monte, Suzanne M., et al.
Publicado: (2023)

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines
por: Ott, Brian R., et al.
Publicado: (2018)

Metabolomic Characterization of Cerebrospinal Fluid from Intracranial Bacterial Infection Pediatric Patients: A Pilot Study
por: Wang, Yiwen, et al.
Publicado: (2021)

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment
por: Cassol, Edana, et al.
Publicado: (2014)

Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease
por: Brinkley, Tina E., et al.
Publicado: (2022)

Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations
por: Panyard, Daniel J., et al.
Publicado: (2021)

Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria
por: Davison, Andrew S., et al.
Publicado: (2022)

Day–night fluctuations in choroid plexus transcriptomics and cerebrospinal fluid metabolomics
por: Edelbo, Beatriche Louise, et al.
Publicado: (2023)

Metabolomics of cerebrospinal fluid reveals prognostic biomarkers in pediatric status epilepticus
por: Wang, Tianqi, et al.
Publicado: (2023)

Multiomics Analysis of Structural Magnetic Resonance Imaging of the Brain and Cerebrospinal Fluid Metabolomics in Cognitively Normal and Impaired Adults
por: Eldridge, Ronald C., et al.
Publicado: (2022)

A selenium species in cerebrospinal fluid predicts conversion to Alzheimer’s dementia in persons with mild cognitive impairment
por: Vinceti, Marco, et al.
Publicado: (2017)

Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer’s Disease
por: Ashraf, Azhaar, et al.
Publicado: (2019)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS)
por: Skill, Nicholas J., et al.
Publicado: (2019)

Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases
por: Schwarz, Emanuel, et al.
Publicado: (2012)

NMR metabolomics of cerebrospinal fluid differentiates inflammatory diseases of the central nervous system
por: French, Caitlin D., et al.
Publicado: (2018)

Metabolite Profiles of the Cerebrospinal Fluid in Neurosyphilis Patients Determined by Untargeted Metabolomics Analysis
por: Liu, Li-Li, et al.
Publicado: (2019)

Confirmation of neurometabolic diagnoses using age‐dependent cerebrospinal fluid metabolomic profiles
por: Peters, Tessa M. A., et al.
Publicado: (2020)

Time Course of Metabolomic Alterations in Cerebrospinal Fluid After Aneurysmal Subarachnoid Hemorrhage
por: Ho, Wing Mann, et al.
Publicado: (2020)

Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy
por: Luo, Yi, et al.
Publicado: (2020)

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
por: Carlsson, Henrik, et al.
Publicado: (2021)

Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
por: Yan, Jingya, et al.
Publicado: (2021)

Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
por: Shang, Pei, et al.
Publicado: (2022)

Cerebrospinal Fluid Metabolomics Identified Ongoing Analgesic Medication in Neuropathic Pain Patients
por: Bäckryd, Emmanuel, et al.
Publicado: (2023)

Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis
por: Židó, Michal, et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
por: Kaiser, Elmar, et al.
Publicado: (2011)

Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia
por: van Wijk, Nick, et al.
Publicado: (2017)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ubpibm4cvvgmidcvrrncv9pk2k